Will cervical screening remain cost‐effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

2012 • 714 citations

US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines

2015 • 646 citations

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

2008 • 613 citations

Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010

2013 • 510 citations

Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine

2009 • 501 citations

Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study

2014 • 279 citations

Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease

2012 • 271 citations

<scp>HPV</scp>‐negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis

2014 • 185 citations

Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing

2007 • 144 citations

The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds

2014 • 143 citations

The Expected Impact of HPV Vaccination on the Accuracy of Cervical Cancer Screening: The Need for a Paradigm Change

2009 • 113 citations

Precancerous changes in the cervix and risk of subsequent preterm birth

2006 • 112 citations

Clinical Human Papillomavirus Detection Forecasts Cervical Cancer Risk in Women Over 18 Years of Follow-Up

2012 • 111 citations

Modeling Preventative Strategies against Human Papillomavirus-Related Disease in Developed Countries

2012 • 105 citations

Risk Assessment to Guide the Prevention of Cervical Cancer

2008 • 96 citations

The predicted effect of changes in cervical screening practice in the UK: results from a modelling study

2004 • 95 citations

The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon

2014 • 83 citations

Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine

2013 • 78 citations

MAVARIC – a comparison of automation-assisted and manual cervical screening: a randomised controlled trial

2011 • 60 citations

Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand

2016 • 56 citations

Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years

2010 • 45 citations

Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study

2012 • 37 citations

Impact of vaccine protection against multiple HPV types on the cost-effectiveness of cervical screening

2012 • 31 citations

The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England

2013 • 27 citations

Testing previous model predictions against new data on human papillomavirus vaccination program outcomes

2014 • 17 citations

Pilot study will assess whether HPV test should replace smears to screen for cervical cancer

2012 • 11 citations

Prostate Cancer Screening in Jamaica: Results of the Largest National Screening Clinic

2016 • 6 citations